agilon health, inc. (NYSE:AGL) Receives Average Rating of "Hold" from Brokerages

Shares of agilon health, inc. (NYSE:AGL - Get Free Report) have earned an average rating of "Hold" from the seventeen research firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have given a buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $4.37.

A number of equities research analysts have weighed in on the stock. Sanford C. Bernstein upgraded shares of agilon health from a "market perform" rating to an "outperform" rating and upped their price objective for the stock from $3.30 to $8.50 in a report on Tuesday. Royal Bank of Canada upped their price target on agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a research note on Wednesday, February 26th. Needham & Company LLC reiterated a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Citigroup raised agilon health from a "sell" rating to a "neutral" rating and boosted their target price for the stock from $1.75 to $2.25 in a report on Friday, January 10th. Finally, Macquarie began coverage on agilon health in a report on Monday, December 16th. They set a "neutral" rating and a $3.00 price target for the company.

agilon health Stock Up 25.1 %

Shares of NYSE:AGL traded up $1.07 during midday trading on Friday, reaching $5.32. The company's stock had a trading volume of 21,169,702 shares, compared to its average volume of 4,696,214. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a 50 day moving average of $3.83 and a 200-day moving average of $3.02. The firm has a market capitalization of $2.19 billion, a P/E ratio of -5.65 and a beta of 0.38. agilon health has a 12-month low of $1.50 and a 12-month high of $7.73.

Remove Ads

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Intech Investment Management LLC bought a new stake in agilon health in the 3rd quarter worth approximately $228,000. MetLife Investment Management LLC grew its holdings in shares of agilon health by 114.8% in the third quarter. MetLife Investment Management LLC now owns 167,789 shares of the company's stock worth $659,000 after acquiring an additional 89,675 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of agilon health by 6.3% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 640,048 shares of the company's stock worth $2,515,000 after acquiring an additional 37,725 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new stake in agilon health during the third quarter valued at $28,000. Finally, Centiva Capital LP bought a new position in agilon health in the third quarter valued at about $651,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.